Micafungin Sodium Patent Expiration
Micafungin Sodium is Used for treating candidiasis infections in various settings, including esophageal candidiasis, candidemia, and candida peritonitis. It was first introduced by Astellas Pharma Us Inc
Micafungin Sodium Patents
Given below is the list of patents protecting Micafungin Sodium, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Mycamine |
US6774104 (Pediatric) | Stabilized pharmaceutical composition in lyophilized form |
Jul 08, 2021
(Expired) | Astellas |
| Mycamine | US6774104 | Stabilized pharmaceutical composition in lyophilized form |
Jan 08, 2021
(Expired) | Astellas |
| Mycamine | US6107458 | Cyclic hexapeptides having antibiotic activity |
Mar 16, 2019
(Expired) | Astellas |
| Mycamine | US6265536 | Cyclic hexapeptides having antibiotic activity |
Sep 29, 2015
(Expired) | Astellas |
Micafungin Sodium's Family Patents
Explore Our Curated Drug Screens
Micafungin Sodium Generic API Manufacturers
Several generic applications have been filed for Micafungin Sodium. The first generic version for Micafungin Sodium was by Fresenius Kabi Usa Llc and was approved on May 17, 2019. And the latest generic version is by Qilu Pharmaceutical Hainan Co Ltd and was approved on Apr 3, 2025.
Given below is the list of companies who have filed for Micafungin Sodium generic, along with the locations of their manufacturing plants worldwide.
1. APOTEX
Apotex Inc has filed for 2 different strengths of generic version for Micafungin Sodium. Given below are the details of the strengths of this generic introduced by Apotex.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 50MG BASE/VIAL | injectable | Discontinued | INTRAVENOUS | N/A | Nov 5, 2020 |
| EQ 100MG BASE/VIAL | injectable | Discontinued | INTRAVENOUS | N/A | Nov 5, 2020 |
Manufacturing Plant Locations New
Apotex's manufacturing plants are situated in 3 countries - United States, Canada, India. Given below are the details of these plant locations as well as the firm names of Apotex as present at those locations.
| Country | City | Firm Name | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||
| Canada |
| |||||||||||||
| India |
| |||||||||||||
2. BIOCON PHARMA
Biocon Pharma Ltd has filed for 2 different strengths of generic version for Micafungin Sodium. Given below are the details of the strengths of this generic introduced by Biocon Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 50MG BASE/VIAL | injectable | Prescription | INTRAVENOUS | AP | May 29, 2024 |
| EQ 100MG BASE/VIAL | injectable | Prescription | INTRAVENOUS | AP | May 29, 2024 |
Manufacturing Plant Locations New
Biocon Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Biocon Pharma as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||
3. FRESENIUS KABI USA
Fresenius Kabi Usa Llc has filed for 2 different strengths of generic version for Micafungin Sodium. Given below are the details of the strengths of this generic introduced by Fresenius Kabi Usa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 50MG BASE/VIAL | injectable | Prescription | INTRAVENOUS | AP | May 17, 2019 |
| EQ 100MG BASE/VIAL | injectable | Prescription | INTRAVENOUS | AP | May 17, 2019 |
Manufacturing Plant Locations New
Fresenius Kabi Usa's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Fresenius Kabi Usa as present at those locations.
| Country | City | Firm Name | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||
4. HIKMA
Hikma Pharmaceuticals International Ltd has filed for 2 different strengths of generic version for Micafungin Sodium. Given below are the details of the strengths of this generic introduced by Hikma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 100MG BASE/VIAL | injectable | Prescription | INTRAVENOUS | AP | Jul 9, 2021 |
| EQ 50MG BASE/VIAL | injectable | Prescription | INTRAVENOUS | AP | Jul 9, 2021 |
Manufacturing Plant Locations New
Hikma's manufacturing plants are situated in 3 countries - United States, Portugal, Jordan. Given below are the details of these plant locations as well as the firm names of Hikma as present at those locations.
| Country | City | Firm Name | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||
| Portugal |
| |||||||||
| Jordan |
| |||||||||
5. JIANGSU HANSOH PHARM
Jiangsu Hansoh Pharmaceutical Group Co Ltd has filed for 2 different strengths of generic version for Micafungin Sodium. Given below are the details of the strengths of this generic introduced by Jiangsu Hansoh Pharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 50MG BASE/VIAL | injectable | Prescription | INTRAVENOUS | AP | Jul 9, 2021 |
| EQ 100MG BASE/VIAL | injectable | Prescription | INTRAVENOUS | AP | Jul 9, 2021 |
Manufacturing Plant Locations New
Jiangsu Hansoh Pharm's manufacturing plants are situated in 1 country - China. Given below are the details of these plant locations as well as the firm names of Jiangsu Hansoh Pharm as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| China |
| |||||
6. MEITHEAL
Meitheal Pharmaceuticals Inc has filed for 2 different strengths of generic version for Micafungin Sodium. Given below are the details of the strengths of this generic introduced by Meitheal.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 50MG BASE/VIAL | injectable | Prescription | INTRAVENOUS | AP | Sep 28, 2022 |
| EQ 100MG BASE/VIAL | injectable | Prescription | INTRAVENOUS | AP | Sep 28, 2022 |
7. QILU PHARM HAINAN
Qilu Pharmaceutical Hainan Co Ltd has filed for 2 different strengths of generic version for Micafungin Sodium. Given below are the details of the strengths of this generic introduced by Qilu Pharm Hainan.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 50MG BASE/VIAL | injectable | Prescription | INTRAVENOUS | AP | Apr 3, 2025 |
| EQ 100MG BASE/VIAL | injectable | Prescription | INTRAVENOUS | AP | Apr 3, 2025 |
8. XELLIA PHARMS APS
Xellia Pharmaceuticals Aps has filed for 2 different strengths of generic version for Micafungin Sodium. Given below are the details of the strengths of this generic introduced by Xellia Pharms Aps.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 50MG BASE/VIAL | injectable | Prescription | INTRAVENOUS | AP | Jun 2, 2021 |
| EQ 100MG BASE/VIAL | injectable | Prescription | INTRAVENOUS | AP | Jun 2, 2021 |
9. ZYDUS PHARMS
Zydus Pharmaceuticals Usa Inc has filed for 2 different strengths of generic version for Micafungin Sodium. Given below are the details of the strengths of this generic introduced by Zydus Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 50MG BASE/VIAL | injectable | Prescription | INTRAVENOUS | AP | Oct 24, 2022 |
| EQ 100MG BASE/VIAL | injectable | Prescription | INTRAVENOUS | AP | Oct 24, 2022 |